1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | Prior to arrival at facility Licensing Program Analyst (LPA) Victoria Brown asked the Business Office Manager the following questions: In the last 10 days, has anyone who is regularly present in the home/facility, including persons in care, or staff developed any of the following symptoms not associated with a pre-existing condition? Fever or chills, Cough, Shortness of breath/difficulty breathing, Fatigue, Muscle or body aches, Headaches, New loss of taste or smell, Sore throat, Congestion or runny nose, Nausea or vomiting, and Diarrhea. Have any individuals Tested positive for COVID-19 with a laboratory confirmed test? Have any individuals Been exposed to someone who tested positive for COVID-19 w/o wearing appropriate PPE? Have any individuals Been diagnosed with a respiratory infection (e.g., flu, bronchitis) or have any respiratory symptoms, such as a sinus congestion or runny nose? Are any individuals in care, caregivers, or staff being evaluated for COVID-19 by a healthcare worker in a healthcare setting? Have any individuals in care, caregivers, or staff been quarantined for COVID-19 in the past 30 days? Have any individuals in care, caregivers, or staff traveled within the last 14 days, to a country considered to be at high-risk for COVID-19 by the CDC travel website? LPA received a "No" answer to all of the above questions.
Licensing Program Analyst (LPA) Victoria Brown arrived unannounced to conduct a Case Management visit on 7/14/21 at 12:50PM. LPA met with Executive Director/Administrator Donna Bautista-Colmenares and stated the purpose of the visit. LPA attempted to conduct interviews regarding incident reports received indicating medication errors had occurred on several dates. The dates were as follows: 7/14/2020, 8/25/2020, 9/25/2020, 9/26/2020, and 5/26/2021. Additional documentation was requested from the Administrator such as LIC602, training confirmation for staff, Charting Notes, and medication documentation.
Occurrences Need Further Investigation. |